<code id='3F3981847C'></code><style id='3F3981847C'></style>

<acronym id='3F3981847C'></acronym>

<center id='3F3981847C'><center id='3F3981847C'><tfoot id='3F3981847C'></tfoot></center><abbr id='3F3981847C'><dir id='3F3981847C'><tfoot id='3F3981847C'></tfoot><noframes id='3F3981847C'>

<optgroup id='3F3981847C'><strike id='3F3981847C'><sup id='3F3981847C'></sup></strike><code id='3F3981847C'></code></optgroup>

<b id='3F3981847C'><label id='3F3981847C'><select id='3F3981847C'><dt id='3F3981847C'><span id='3F3981847C'></span></dt></select></label></b><u id='3F3981847C'></u>

~~<i id='3F3981847C'><strike id='3F3981847C'><tt id='3F3981847C'><pre id='3F3981847C'></pre></tt></strike></i>~~

Home» comprehensive» leisure time

leisure time

leisure time

author：explore 2025-09-27 15:46:06 Page View：66

Merck — Kena Betancur/Getty Images

MADRID — Merck is paying billions of dollars to partner with Daiichi Sankyo on a series of cancer drugs, underscoring the excitement around targeted chemotherapy treatments.

The deal includes a $4 billion upfront payment and an additional $1.5 billion over the next two years. Up to $16.5 billion more is on the table depending on the success of the drugs in development.

advertisement

The announcement on Thursday night in the United States came on the eve of one the cancer field’s biggest annual conferences, the European Society for Medical Oncology Congress, being held this year in Madrid.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Archived: an online chat discussing Ebola, vaccines, and a new epidemic
Next article： Jerome Adams on the need for new antivirals for Covid

explore

The high cost of giving birth even with insurance

The high cost of giving birth even with insurance

AdobeTheburdenofhighhealthcarecostsandmedicaldebtintheU.S.isnosecret.Medicaldebtaffectsoneinfiveadul

H.R. 3 is the wrong path to lower drug costs

H.R. 3 is the wrong path to lower drug costs

Fromleft,Rep.RichardNeal(D-Mass.)speaksasRep.FrankPallone(D-N.J.)andHouseSpeakerNancyPelosi(D-Calif.

Duchenne breakthrough therapy leaves behind pioneering families

Duchenne breakthrough therapy leaves behind pioneering families

DuchennemusculardystrophyDr.EdwinP.Ewing,Jr./CDCPatFurlongwassittinginherhomeofficeinMiddletown,Ohio

It costs an awful lot of money to give away a kidney

BRENDANSMIALOWSKI/AFP/GettyImages“Allofyourmedicalandsurgicalexpenseswillbepaidbyyourrecipient’sinsu

read more